Solu Therapeutics
- Employees
- 1–10
- Business Model
- B2B
- Website
- solutherapeutics.com
- Total Funding
- $72.0M
- Last Round
- $41.0M Series AApr 2025
- Rounds
- 2
About
Biotech company developing groundbreaking medicines to transform disease treatment.
Summary
Solu Therapeutics is a Biotech company. It has raised $72.0M in total across 2 rounds, most recently a $41.0M Series A round in Apr 2025. Investors include Eli Lilly and Company, Hengdian Group Capital and DCVC (Data Collab).
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...